Market closed
Avantor/$AVTR
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Avantor
Avantor Inc provider of products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company has three geographic segments: the Americas, Europe, and AMEA. The company's product group consists of Equipment & instrumentation, Services & specialty procurement, Proprietary materials & consumables, and Third-party materials & consumables. Materials & consumables include high-purity chemicals and reagents, lab products and supplies, specialized formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, and education and microbiology and clinical trial kits, peristaltic pumps and fluid handling tips.
Ticker
$AVTR
Sector
Trading on
NYSE
Industry
Life Sciences Tools & Services
Headquarters
Employees
13,500
Website
Avantor Metrics
BasicAdvanced
$13B
18.28
$1.04
1.28
-
Price and volume
Market cap
$13B
Beta
1.28
52-week high
$28.00
52-week low
$18.49
Average daily volume
5M
Financial strength
Current ratio
1.069
Quick ratio
0.646
Long term debt to equity
54.304
Total debt to equity
68.088
Interest coverage (TTM)
2.92%
Management effectiveness
Return on assets (TTM)
3.18%
Return on equity (TTM)
12.69%
Valuation
Price to earnings (TTM)
18.279
Price to revenue (TTM)
1.904
Price to book
2.17
Price to tangible book (TTM)
-4.4
Price to free cash flow (TTM)
18.669
Growth
Revenue change (TTM)
-2.64%
Earnings per share change (TTM)
121.28%
3-year revenue growth (CAGR)
-2.80%
3-year earnings per share growth (CAGR)
6.96%
What the Analysts think about Avantor
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Avantor stock.
Avantor Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Avantor Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Avantor News
AllArticlesVideos
Avantor, Inc. (AVTR) Q4 2024 Earnings Call Transcript
Seeking Alpha·5 days ago
Life Science Tools Firm Avantor Reports Mixed Q4 Earnings, Forecasts Organic Sales Growth In 2025
Benzinga·5 days ago
TriLink BioTechnologies® Partners with Avantor® to Expand Nucleic Acid Solutions in Europe
Business Wire·1 week ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Avantor stock?
Avantor (AVTR) has a market cap of $13B as of February 12, 2025.
What is the P/E ratio for Avantor stock?
The price to earnings (P/E) ratio for Avantor (AVTR) stock is 18.28 as of February 12, 2025.
Does Avantor stock pay dividends?
No, Avantor (AVTR) stock does not pay dividends to its shareholders as of February 12, 2025.
When is the next Avantor dividend payment date?
Avantor (AVTR) stock does not pay dividends to its shareholders.
What is the beta indicator for Avantor?
Avantor (AVTR) has a beta rating of 1.28. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.